Neofitos Stefanides, MD
Orthopaedic Surgery · Bayside, NYNPI 1689880429
Payments from drug & device makers
Across 53 payments — averaging $129.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$3K
- Gotham Surgical Solutions & Devices, Inc.$2K
- Johnson & Johnson$2K
- Nevro Corp.$244
- Globus Medical$170
- Smith+Nephew$170
- plus $330 from 5 others
What the payments were for
- Travel & lodging$2,26533%
- Food & beverage$2,79741%
- Education$1,81526%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 18 | $2,551 |
| Gotham Surgical Solutions & Devices, Inc. | 2 | $1,815 |
| Johnson & Johnson | 22 | $1,597 |
| Nevro Corp. | 2 | $244 |
| Globus Medical | 1 | $170 |
| Smith+Nephew | 2 | $170 |
| Zimvie Inc. | 1 | $105 |
| Boston Scientific | 1 | $104 |
| Medtronic | 1 | $93 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Fidia Pharma USA Inc. | 2 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RIGIDLOOP$1,711
- DYNACORD$631
- HEALIX$515
- TRUESPAN$515
- HEALIX KNOTLESS PEEK$488
- VAPR$264
- Senza$170
- Dyonics Bonecutter$150
- REGENETEN Shoulder$150
- Senza Spinal Cord Stimulation System$139
- TRUESPAN ORTHOCORD$125
- FMS$123
- SPEEDTRAP$119
- Biomet OrthoPak Non-invasive Bone Growth Stimulator System$105
- Omnia$105
- GENERAL PAIN MANAGEMENT$104
How this compares
$6,878 in reported general payments places this provider in the 55th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 60 | $56,530 |
| Lidocaine | 38 | $6,447 |
| Gabapentin | 132 | $692 |
| Meloxicam | 189 | $497 |
| Celecoxib | 50 | $483 |
| Methylprednisolone | 60 | $445 |
| Ondansetron OdtOndansetron | 41 | $393 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $231 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $113 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bayside
- Anthony RomeoNew York$27M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$14.1M
- William RicciNew York$11.6M
- Steven HaasNew York$11.5M
- Giles ScuderiNew York$10.9M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.